1.
Open Forum Infect Dis
; 11(6): ofae294, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38868307
RESUMO
Severe mpox has been observed in people with advanced human immunodeficiency virus (HIV). We describe clinical outcomes of 13 patients with advanced HIV (CD4 <200â cells/µL), severe mpox, and multiorgan involvement. Despite extended tecovirimat courses and additional agents, including vaccinia immune globulin, cidofovir, and brincidofovir, this group experienced prolonged hospitalizations and high mortality.